HomeACAD • NASDAQ
add
ACADIA Pharmaceuticals Inc
Previous close
$24.39
Day range
$24.20 - $25.20
Year range
$13.40 - $26.65
Market cap
4.11B USD
Avg Volume
1.72M
P/E ratio
21.92
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 278.63M | 11.27% |
Operating expense | 133.40M | 0.08% |
Net income | 71.78M | 119.07% |
Net profit margin | 25.76 | 96.79% |
Earnings per share | 0.42 | 110.00% |
EBITDA | 38.71M | 13.13% |
Effective tax rate | -60.96% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 847.02M | 49.83% |
Total assets | 1.33B | 36.23% |
Total liabilities | 413.50M | 3.46% |
Total equity | 917.27M | — |
Shares outstanding | 169.18M | — |
Price to book | 4.50 | — |
Return on assets | 6.99% | — |
Return on capital | 9.66% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 71.78M | 119.07% |
Cash from operations | 74.29M | 17.46% |
Cash from investing | -79.35M | 3.77% |
Cash from financing | 9.42M | 3,416.04% |
Net change in cash | 4.36M | 122.96% |
Free cash flow | 33.71M | -44.80% |
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
654